tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

MIST Stock Latest News

Milestone Pharmaceuticals files $250M mixed securities shelf
The FlyMilestone Pharmaceuticals files $250M mixed securities shelf
1M ago
MIST
Milestone Pharmaceuticals Prepares for CARDAMYST Approval
PremiumCompany Announcements
Milestone Pharmaceuticals Prepares for CARDAMYST Approval
1M ago
MIST
Milestone Pharmaceuticals reports Q3 EPS (14c) vs. (35c) last year
PremiumThe Fly
Milestone Pharmaceuticals reports Q3 EPS (14c) vs. (35c) last year
1M ago
MIST
MIST Earnings this Week: How Will it Perform?
PremiumPre-Earnings
MIST Earnings this Week: How Will it Perform?
1M ago
MIST
Milestone partner announces Phase 3 study of etripamil met primary endpoint
PremiumThe Fly
Milestone partner announces Phase 3 study of etripamil met primary endpoint
4M ago
MIST
Milestone Pharmaceuticals Welcomes New Directors and Auditor
PremiumCompany AnnouncementsMilestone Pharmaceuticals Welcomes New Directors and Auditor
4M ago
8K
MIST
Milestone Pharmaceuticals appoints Joseph Papa to board of directors
Premium
The Fly
Milestone Pharmaceuticals appoints Joseph Papa to board of directors
4M ago
MIST
Milestone Pharmaceuticals initiated with a Buy at Rodman & Renshaw
Premium
The Fly
Milestone Pharmaceuticals initiated with a Buy at Rodman & Renshaw
4M ago
MIST
Milestone Pharmaceuticals’ Promising Drug Advancements
PremiumCompany Announcements
Milestone Pharmaceuticals’ Promising Drug Advancements
5M ago
MIST
Milestone Pharmaceuticals Eyes 2025 for CARDAMYST Launch
PremiumCompany Announcements
Milestone Pharmaceuticals Eyes 2025 for CARDAMYST Launch
5M ago
MIST
Milestone Pharmaceuticals reports Q2 EPS (14c), consensus (19c)
PremiumThe Fly
Milestone Pharmaceuticals reports Q2 EPS (14c), consensus (19c)
5M ago
MIST
Milestone Pharmaceuticals Bolsters Board with New Directors
PremiumCompany Announcements
Milestone Pharmaceuticals Bolsters Board with New Directors
5M ago
MIST
Milestone Pharmaceuticals appoints Duty, Saik to board of directors
PremiumThe FlyMilestone Pharmaceuticals appoints Duty, Saik to board of directors
5M ago
ARVN
MIST
Milestone Pharmaceuticals announces FDA acceptance of NDA for CARDAMYST
Premium
The Fly
Milestone Pharmaceuticals announces FDA acceptance of NDA for CARDAMYST
7M ago
MIST
Milestone Pharmaceuticals partners with Arrhythmia Alliance on SVT awareness
Premium
The Fly
Milestone Pharmaceuticals partners with Arrhythmia Alliance on SVT awareness
7M ago
MIST
Milestone Pharmaceuticals Excels with New Drug Update
PremiumCompany Announcements
Milestone Pharmaceuticals Excels with New Drug Update
7M ago
MIST
Milestone Pharmaceuticals reports Q1 EPS (21c), consensus (26c)
PremiumThe Fly
Milestone Pharmaceuticals reports Q1 EPS (21c), consensus (26c)
7M ago
MIST
Is MIST a Buy, Before Earnings?
PremiumPre-Earnings
Is MIST a Buy, Before Earnings?
7M ago
MIST
Milestone’s Etripamil Shows Promise in Self-Managed PSVT Treatment
PremiumCompany Announcements
Milestone’s Etripamil Shows Promise in Self-Managed PSVT Treatment
9M ago
MIST
Milestone: Etripamil ‘effective’ at restoring sinus rhythm in trial
PremiumThe FlyMilestone: Etripamil ‘effective’ at restoring sinus rhythm in trial
9M ago
MIST
Milestone’s Etripamil Aims to Revolutionize PSVT Treatment
Premium
Company Announcements
Milestone’s Etripamil Aims to Revolutionize PSVT Treatment
9M ago
MIST
Milestone Pharmaceuticals announces resubmission of NDA for etripamil
Premium
The Fly
Milestone Pharmaceuticals announces resubmission of NDA for etripamil
9M ago
MIST

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >